본문 바로가기
KERD
논문KCI 등재

초발 정신증 환자에서 Mismatch Negativity를 이용한 1년 간의 예후 예측 연구

Predicting Prognosis in Patients with First Episode Psychosis Using Mismatch Negativity : A 1 Year Follow-up Study

권준수|김민아|장문영|이탁형
대한조현병학회 (Korean Academy of Schizophrenia)|2017.04|대한조현병학회지 (Korean Journal of Schizophrenia Research)|제20권 제1호|pp. 15-22

2

조회

0

다운로드

0

인용

0

참고문헌

주제분류정신과학

초록

Objectives : It has been shown that early intervention is crucial for favorable outcome in patients with schizophrenia. However, development of biomarkers for predicting prognosis of psychotic disorder still requires more research. In this study, we aimed to investigate whether baseline mismatch negativity (MMN) predict prognosis in patients with first episode psychosis (FEP). Methods : Twenty-four patients with FEP and matched healthy controls (HCs) were examined with MMN at baseline, and their clinical status were re-assessed after 1 year. Repeated-measures analysis of variance was performed to compare baseline MMN between the two groups. Multiple regression analysis was used to identify factors predicting prognosis in FEP patients during the follow-up period. Results : MMN amplitudes at baseline were significantly reduced in patients with FEP compared to healthy controls. In the multiple regression analysis, baseline MMN amplitude significantly predicted later improvement of performances on digit span and delayed recall of California Verbal Learning Test. However, baseline MMN did not predicted improvement of clinical symptoms. Conclusion : These results indicate that MMN may be a possible predictor of improvement in cognitive functioning in patients with FEP. Future study with larger sample and longer follow-up period would be needed to confirm the findings of the current study.

Abstract

Objectives : It has been shown that early intervention is crucial for favorable outcome in patients with schizophrenia. However, development of biomarkers for predicting prognosis of psychotic disorder still requires more research. In this study, we aimed to investigate whether baseline mismatch negativity (MMN) predict prognosis in patients with first episode psychosis (FEP). Methods : Twenty-four patients with FEP and matched healthy controls (HCs) were examined with MMN at baseline, and their clinical status were re-assessed after 1 year. Repeated-measures analysis of variance was performed to compare baseline MMN between the two groups. Multiple regression analysis was used to identify factors predicting prognosis in FEP patients during the follow-up period. Results : MMN amplitudes at baseline were significantly reduced in patients with FEP compared to healthy controls. In the multiple regression analysis, baseline MMN amplitude significantly predicted later improvement of performances on digit span and delayed recall of California Verbal Learning Test. However, baseline MMN did not predicted improvement of clinical symptoms. Conclusion : These results indicate that MMN may be a possible predictor of improvement in cognitive functioning in patients with FEP. Future study with larger sample and longer follow-up period would be needed to confirm the findings of the current study.

참고문헌 (54)

  1. McGrath J, "A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology", BMC Med, 2, pp.1~13 (2004)
  2. Edwards J, "Duration of untreated psychosis (DUP) and outcome in schizophrenia", Psychol Med, 32, pp.563~564 (2002)
  3. Ito S, "Differential impacts of duration of untreated psychosis (DUP)on cognitive function in first-episode schizophrenia according to mode of onset", Eur Psychiatry, 30, pp.995~1001 (2015)
  4. Yuksel C, "Gray matter volume in schizophrenia and bipolar disorder with psychotic features", Schizophr Res, 138, pp.177~182 (2012)
  5. Horan WP, "Social cognition in schizophrenia, Part 2: 12-month stability and prediction of functional outcome in first-episode patients", Schizophr Bull, 38, pp.865~872 (2012)
  6. Huang J, "Working memory dysfunctions predict social problem solving skills in schizophrenia", Psychiatry Res, 220, pp.96~101 (2014)
  7. Prouteau A, "The crucial role of sustained attention in community functioning in outpatients with schizophrenia", Psychiatry Res, 129, pp.171~177 (2004)
  8. Green MF, "Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the “right stuff”?", Schizophr Bull, 26, pp.119~136 (2000)
  9. Dell’Osso B, "Can long-term outcomes be improved by shortening the duration of untreated illness in psychiatric disorders? A conceptual framework", Psychopathology, 46, pp.14~21 (2013)
  10. van der Gaag M, "Preventing a first episode of psychosis: meta-analysis of randomized controlled prevention trials of 12 month and longerterm follow-ups", Schizophr Res, 149, pp.56~62 (2013)
  11. Fond G, "The promise of biological markers for treatment response in first-episode psychosis: a systematic review", Schizophr Bull, 41, pp.559~573 (2015)
  12. Dancey JE, "Guidelines for the development and incorporation of biomarker studies in early clinical trials of novel agents", Clin Cancer Res, 16, pp.1745~1755 (2010)
  13. Yener GG, "Brain oscillations as biomarkers in neuropsychiatric disorders: following an interactive panel discussion and synopsis", Suppl Clin Neurophysiol, 62, pp.343~363 (2013)
  14. Bramon E, "Mismatch negativity in schizophrenia: a family study", Schizophr Res, 67, pp.1~10 (2004)
  15. Shin KS, "Aberrant auditory processing in schizophrenia and in subjects at ultra-highrisk for psychosis", Schizophr Bull, 38, pp.1258~1267 (2012)
  16. Light GA, "Electroencephalography (EEG) and event-related potentials (ERPs) with human participants", Curr Protoc Neurosci, 25, pp.21~24 (2010)
  17. Rydkjaer J, "Mismatch negativity and P3a amplitude in young adolescents with first-episode psychosis: a comparison with ADHD", Psychol Med, 47, pp.377~388 (2017)
  18. Sumiyoshi T, "Electrophysiological and neuropsychological predictors of conversion to schizophrenia in at-risk subjects", Front Behav Neurosci, 7, pp.148~ (2013)
  19. Naatanen R, "“Primitive intelligence” in the auditory cortex", Trends Neurosci, 24, pp.283~288 (2001)
  20. Javitt DC, "Impairment of early cortical processing in schizophrenia: an eventrelated potential confirmation study", Biol Psychiatry, 33, pp.513~519 (1993)
  21. Michie PT, "Duration and frequency mismatch negativity in schizophrenia", Clin Neurophysiol, 111, pp.1054~1065 (2000)
  22. Sevik AE, "Neuropsychological performance and auditory event related potentials in schizophrenia patients and their siblings: a family study", Schizophr Res, 130, pp.195~202 (2011)
  23. Kim M, "Impaired mismatch negativity is associated with current functional status rather than genetic vulnerability to schizophrenia", Psychiatry Res, 222, pp.100~106 (2014)
  24. Atkinson RJ, "Duration mismatch negativity and P3a in first-episode psychosis and individuals at ultra-high risk of psychosis", Biol Psychiatry, 71, pp.98~104 (2012)
  25. Hermens DF, "Impaired MMN", P3a complex in first-episode psychosis: cognitive and psychosocial associations, 2010, pp.34, 822~829
  26. Kim M, "Aberrant temporal behavior of mismatch negativity generators in schizophrenia patients and subjects at clinical high risk for psychosis", Clin Neurophysiol, 128, pp.331~339 (2017)
  27. Morey RA, "Neural correlates of automatic and controlled auditory processing in schizophrenia", J Neuropsychiatry Clin Neurosci, 20, pp.419~430 (2008)
  28. Jahshan C, "Automatic sensory information processing abnormalities across the illness course of schizophrenia", Psychol Med, 42, pp.85~97 (2012)
  29. Javitt DC, "Impaired mismatch negativity generation reflects widespread dysfunction of working memory in schizophrenia", Arch Gen Psychiatry, 52, pp.550~558 (2009)
  30. Rissling AJ, "Neurophysiologic markers of abnormal brain activity in schizophrenia", Curr Psychiatry Rep, 12, pp.572~578 (2010)
  31. Kay SR, "The positive and negative syndrome scale (PANSS) for schizophrenia", Schizophr Bull, 13, pp.261~276 (1987)
  32. Yeom TH, "K-WAIS manual" (1992), Korea Guidance
  33. Gardner DM, "International consensus study of antipsychotic dosing", Am J Psychiatry, 167, pp.686~693 (2010)
  34. Hsieh MH, "Auditory event-related potential of subjects with suspected prepsychotic state and first-episode psychosis", Schizophr Res, 140, pp.243~249 (2012)
  35. Richardson JT, "Measures of short-term memory: a historical review", Cortex, 43, pp.635~650 (2007)
  36. Elwood RW, "The California Verbal Learning Test: psychometric characteristics and clinical application", Neuropsychol Rev, 5, pp.173~201 (1995)
  37. Rowland LM, "Frontal Glutamate and gamma-Aminobutyric Acid Levels and Their Associations With Mismatch Negativity and Digit Sequencing Task Performance in Schizophrenia", JAMA Psychiatry, 73, pp.166~174 (2016)
  38. Green MF, "Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria", Biol Psychiatry, 56, pp.301~307 (2004)
  39. Toyomaki A, "Tone duration mismatch negativity deficits predict impairment of executive function in schizophrenia", Prog Neuropsychopharmacol Biol Psychiatry, 32, pp.95~99 (2008)
  40. Wynn JK, "Mismatch negativity, social cognition, and functioning in schizophrenia patients", Biol Psychiatry, 67, pp.940~947 (2010)
  41. Kawakubo Y, "Support for an association between mismatch negativity and social functioning in schizophrenia", Prog Neuropsychopharmacol Biol Psychiatry, 30, pp.1367~1368 (2006)
  42. Kawakubo Y, "Phonetic mismatch negativity predicts verbal memory deficits in schizophrenia", Neuroreport, 17, pp.1043~1046 (2006)
  43. Umbricht D, "Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia", Arch Gen Psychiatry, 57, pp.1139~1147 (2000)
  44. Pang EW, "Dissociation of the mismatch negativity and processing negativity attentional waveforms with nitrous oxide", Psychophysiology, 36, pp.552~558 (1999)
  45. Morris RG, "Selective impairment of learning and blockade of long-term potentiation by an Nmethyl-D-aspartate receptor antagonist, AP5", Nature, 319, pp.774~776 (1985)
  46. Collingridge GL, "The NMDA receptor as a target for cognitive enhancement", Neuropharmacology, 64, pp.13~26 (2013)
  47. Preskorn SH, "Normalizing effects of EVP-6124, an alpha-7 nicotinic partial agonist, on event-related potentials and cognition: a proof of concept, randomized trial in patients with schizophrenia", J Psychiatr Pract, 20, pp.12~24 (2014)
  48. Fisher DJ, "Effects of auditory hallucinations on the mismatch negativity (MMN) in schizophrenia as measured by a modified ‘optimal’ multifeature paradigm", Int J Psychophysiol, 81, pp.245~251 (2011)
  49. During S, "Effects of Blocking D2", D3 Receptors on Mismatch Negativity and P3a Amplitude of Initially Antipsychotic Naive, First Episode Schizophrenia Patients, 2015, pp.19, pyv109~
  50. Korostenskaja M, "Effects of olanzapine on auditory P300 and mismatch negativity (MMN) in schizophrenia spectrum disorders", Prog Neuropsychopharmacol Biol Psychiatry, 29, pp.543~548 (2005)
  51. Umbricht D, "Effects of clozapine on auditory event-related potentials in schizophrenia", Biol Psychiatry, 44, pp.716~725 (1998)
  52. Rissling AJ, "Disentangling early sensory information processing deficits in schizophrenia", Clin Neurophysiol, 123, pp.1942~1949 (2012)
  53. Zhou Z, "Effect of aripiprazole on mismatch negativity (MMN) in schizophrenia", PLoS One, 8, pp.e52186~ (2013)
  54. Nuechterlein KH, "The early longitudinal course of cognitive deficits in schizophrenia", J Clin Psychiatry, 75, pp.25~29 (2014)

관련 논문AI추천

Mismatch Negativity Indices as a Prognostic Factor for Remission in SchizophreniaHo-Sung Lee, Hwa-Young Lee, Ji Sun Kim, Se-Hoon Shim, Sungkean Kim, Young Joon Kwon대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2020 · 제18권 제1호조현병 환자에서의 Mismatch Negativity와 기능 상태의 연관성 연구권준수, 김민아, 김성년, 이민희, 이수지대한조현병학회 · 대한조현병학회지2013 · 제16권 제2호조현병 환자를 대상으로 시행한 Oddball Paradigm 중 표준자극에 대한 뇌파 반응의 시간-주파수 분석: 예비연구이미경, 최민호대한신경정신의학회 · 신경정신의학2021 · 제60권 제4호조현병 환자의 인지기능과 뇌 사건유발전위의 관계김가영, 민정아, 채정호대한생물정신의학회 · 생물정신의학2012 · 제19권 제3호Predicting Symptomatic and Functional Improvements over 1 Year in Patients with First-Episode Psychosis Using Resting-State ElectroencephalographyAndi J. Tanra, Jun Soo Kwon, Minah Kim, Rinvil Renaldi, Tak Hyung Lee, Yoo Bin Kwak대한신경정신의학회 · PSYCHIATRY INVESTIGATION2019 · 제16권 제9호조현병 환자의 치료 반응에 따른 Mismatch Negativity 변화강원섭, 김종우, 이소연, 이의혁대한생물정신의학회 · 생물정신의학2017 · 제24권 제4호

이 간행물의 다른 논문 (2건)

조현병 환자에서 비전형항정신병약물 사용시 대사지표에 미치는 영향 조사 : 3년 추적연구박은경, 이종일, 윤해주, 배하현pp. 5-14항-NMDA-수용체 뇌염으로 진단된 긴장증 사례이중선, 김창윤, 전명욱, 이세정pp. 23-27
원문 보기